近来,对中风的有效的药物疗法之一是对脑血栓采用了积极的血栓溶解剂,即血纤维蛋白溶酶原的激活剂——尿激酶的应用已被重视了.但有关其效能的基础和临床方面的研究尚未达到十全十美的阶段,其使用方法和使用剂量,特别是大剂量静脉点滴疗法的疗效等还是些至关重要的课题.本文作者试用了尿激酶240,000单位的大剂量静脉点滴疗法,现简要报告如下. Recently, one of the effective drug therapies for stroke has been the use of an active thrombolytic agent for cerebral thrombosis, namely the use of plasminogen activator urokinase, but the basis for its efficacy And clinical studies have not yet reached the perfect stage, the use of methods and the use of doses, especially high-dose intravenous drip therapy efficacy is still a crucial issue.The author of the trial of 240,000 units of urokinase high-dose intravenous drip therapy The brief report is as follows.